AR074437A1 - Tratamiento para la glomerulonefritis - Google Patents
Tratamiento para la glomerulonefritisInfo
- Publication number
- AR074437A1 AR074437A1 ARP090104622A ARP090104622A AR074437A1 AR 074437 A1 AR074437 A1 AR 074437A1 AR P090104622 A ARP090104622 A AR P090104622A AR P090104622 A ARP090104622 A AR P090104622A AR 074437 A1 AR074437 A1 AR 074437A1
- Authority
- AR
- Argentina
- Prior art keywords
- glomerulonephritis
- compound
- nephritis
- patient
- effective amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describe un tratamiento para la glomerulonefritis, y otras disfunciones renales, usando un compuesto de la fórmula 1. Reivindicación 4: Un método de tratar la glomerulonefritis, que comprende administrar a un paciente que lo necesita una cantidad eficaz de un compuesto que es un inhibidor Syk. Reivindicación 5: Un método para tratar la enfermedad renal, que comprende administrar a un paciente con necesidad del mismo una cantidad eficaz de un compuesto de la formula (1) o sus N-óxidos profármacos, sales o solvatos farmacéuticamente aceptables correspondientes, en donde la enfermedad renal se selecciona entre: glomerulonefritis, el síndrome de Goodpasture, glomerulonefritis mesangiocapilar, glomerulonefritis postinfecciosa, púrpura de Henoch-Schönlein, enfermedad de Berger, glomerulonefritis membranosa, glomeruloescIerosis segmental focal, nefritis de lupus, nefritis hereditaria, glomerulonephritis proliferativa mesangial, enfermedad de la membrana basal fina, nephritis crescéntica, y glomerulonefritis de progresión rápida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11947608P | 2008-12-03 | 2008-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074437A1 true AR074437A1 (es) | 2011-01-19 |
Family
ID=41571088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104622A AR074437A1 (es) | 2008-12-03 | 2009-12-01 | Tratamiento para la glomerulonefritis |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110251219A1 (es) |
| EP (1) | EP2373316A1 (es) |
| JP (1) | JP2012510519A (es) |
| KR (1) | KR20110117650A (es) |
| CN (1) | CN102238952A (es) |
| AR (1) | AR074437A1 (es) |
| AU (1) | AU2009322478A1 (es) |
| BR (1) | BRPI0922216A2 (es) |
| CA (1) | CA2745199A1 (es) |
| IL (1) | IL213287A0 (es) |
| MX (1) | MX2011004789A (es) |
| PA (1) | PA8851701A1 (es) |
| RU (1) | RU2011127128A (es) |
| TW (1) | TW201032810A (es) |
| UY (1) | UY32289A (es) |
| WO (1) | WO2010065571A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2441755A1 (en) | 2010-09-30 | 2012-04-18 | Almirall, S.A. | Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors |
| EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008033789A2 (en) * | 2006-09-11 | 2008-03-20 | Ticona Llc | Method of measuring fiber length for long fiber reinforced thermoplastic composites |
| CL2007002617A1 (es) | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
-
2009
- 2009-12-01 PA PA20098851701A patent/PA8851701A1/es unknown
- 2009-12-01 AR ARP090104622A patent/AR074437A1/es unknown
- 2009-12-02 CN CN2009801486160A patent/CN102238952A/zh active Pending
- 2009-12-02 CA CA2745199A patent/CA2745199A1/en not_active Abandoned
- 2009-12-02 RU RU2011127128/15A patent/RU2011127128A/ru unknown
- 2009-12-02 WO PCT/US2009/066304 patent/WO2010065571A1/en active Application Filing
- 2009-12-02 MX MX2011004789A patent/MX2011004789A/es not_active Application Discontinuation
- 2009-12-02 EP EP09768276A patent/EP2373316A1/en not_active Withdrawn
- 2009-12-02 JP JP2011539641A patent/JP2012510519A/ja not_active Withdrawn
- 2009-12-02 AU AU2009322478A patent/AU2009322478A1/en not_active Abandoned
- 2009-12-02 KR KR1020117015331A patent/KR20110117650A/ko not_active Application Discontinuation
- 2009-12-02 TW TW098141090A patent/TW201032810A/zh unknown
- 2009-12-02 BR BRPI0922216A patent/BRPI0922216A2/pt not_active Application Discontinuation
- 2009-12-03 UY UY0001032289A patent/UY32289A/es not_active Application Discontinuation
-
2011
- 2011-05-31 IL IL213287A patent/IL213287A0/en unknown
- 2011-06-02 US US13/151,916 patent/US20110251219A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW201032810A (en) | 2010-09-16 |
| WO2010065571A1 (en) | 2010-06-10 |
| CN102238952A (zh) | 2011-11-09 |
| RU2011127128A (ru) | 2013-01-10 |
| UY32289A (es) | 2010-06-30 |
| PA8851701A1 (es) | 2010-07-27 |
| US20110251219A1 (en) | 2011-10-13 |
| CA2745199A1 (en) | 2010-06-10 |
| MX2011004789A (es) | 2011-05-30 |
| EP2373316A1 (en) | 2011-10-12 |
| IL213287A0 (en) | 2011-07-31 |
| KR20110117650A (ko) | 2011-10-27 |
| JP2012510519A (ja) | 2012-05-10 |
| BRPI0922216A2 (pt) | 2015-12-29 |
| AU2009322478A1 (en) | 2011-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
| RU2008139905A (ru) | Фармацевтическая композиция для наружного применения | |
| BR112014003237A2 (pt) | compostos de indazol, composições e métodos de uso | |
| PE20160180A1 (es) | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos. | |
| MA39995B1 (fr) | Composés destinés à traiter l'amyotrophie spinale | |
| UY33480A (es) | Compuestos terapeuticos, composicion farmaceutica que lo comprende, metodo de tratamiento y su uso para la manufactura de un medicamento. | |
| CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
| ECSP12011799A (es) | Compuestos de espiropiperidina y uso farmacéutico de los mismos | |
| MA40225A (fr) | Composés dihydroisoquinolinone substitués | |
| MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
| AR099134A1 (es) | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina | |
| CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
| AR093244A1 (es) | Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2 | |
| CL2012002944A1 (es) | Compuestos derivados de amino-pirimidinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
| CL2012002945A1 (es) | Compuestos derivados de amino-piridazinas; composiciones farmacéuticas que los comprenden; y su uso para el tratamiento de una enfermedad afección seleccionada de trastornos neuromusculares, esclerosis lateral amiotrófica, miastenia grave, entre otras. | |
| EA201001680A1 (ru) | Соединения бензолсульфонамидтиазола и оксазола | |
| EA201490419A1 (ru) | Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания | |
| CL2011002989A1 (es) | Compuestos heterociclicos inhibidores de la endopeptidasa neutra (nep); composicion farmaceutica; combinacion farmaceutica; uso del compuesto patra tratar un trastorno o enfermedad tal como hipertencion, insuficiencia cardiaca, insuficiencia renal, epilepsia, sindrome metabolico, entre otros. | |
| EA201100971A1 (ru) | Производные пиримидининдола для лечения злокачественного новообразования | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| CR20120296A (es) | Nuevos compuestos de espiropiperidina | |
| AR103680A1 (es) | Inhibidores selectivos de bace1 | |
| CL2008000089A1 (es) | Compuestos derivados de 2,4-pirimidinona condensada con un heterociclo, inhibidores de pde-4; composicion farmaceutica; combinacion farmaceutica; procedimiento de preparacion de los compuestos, utiles para tratar trastornos inmunes e inflamatorios. | |
| EA202191519A1 (ru) | Модуляторы trex1 | |
| EA201691759A1 (ru) | Композиции и способы лечения легочной гипертензии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |